PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 21, 2008Diabetes420 citationsOpen Access

Dapagliflozin, a Selective SGLT2 Inhibitor, Improves Glucose Homeostasis in Normal and Diabetic Rats

SHSong‐Ping HanDHDeborah HaganJTJoseph R. Taylor

Key Points

Key points are not available for this paper at this time.

Abstract

These data suggest that dapagliflozin has the potential to be an efficacious treatment for type 2 diabetes.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Han et al. (2008) studied this question.

synapsesocial.com/papers/69d862c205ee2ba81dbefa42https://doi.org/10.2337/db07-1472
Ask AI
Helpful
Bookmark
Share
View Full Paper